Glucose-dependent insulinotropic polypeptide in diabetes and obesity / 中华内分泌代谢杂志
Chinese Journal of Endocrinology and Metabolism
;
(12): 735-738, 2015.
Artículo
en Chino
| WPRIM
| ID: wpr-476573
ABSTRACT
[Summary] Glucose-dependent insulinotropic polypeptide ( GIP) is known to promote the release of insulin fromβcells, but this function suffers from a defect in obese patients. More and more evidences suggest that GIP is the bridge between a high-fat diet, obesity, insulin resistance, and type 2 diabetes. With the deepening of research in GIP in type 2 diabetes and obesity, GIP may provide new ideas for the treatment of type 2 diabetes and obesity.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Idioma:
Chino
Revista:
Chinese Journal of Endocrinology and Metabolism
Año:
2015
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS